Ignite Creation Date:
2024-05-06 @ 9:24 AM
Last Modification Date:
2024-10-26 @ 12:14 PM
Study NCT ID:
NCT02975271
Status:
TERMINATED
Last Update Posted:
2021-05-20
First Post:
2016-11-22
Brief Title:
Study of the Efficacy Safety Tolerability of Serlopitant for Pruritus Itch After Burn Injury
Sponsor:
Vyne Therapeutics Inc
Organization:
Vyne Therapeutics Inc
Study Overview
Official Title:
A Randomized Double-Blind Placebo-Controlled Study of the Efficacy Safety and Tolerability of Serlopitant for the Treatment of Pruritus Following Burn Injury
Status:
TERMINATED
Status Verified Date:
2021-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Business Reasons
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
AUBURN
Brief Summary:
Study of the Efficacy Safety Tolerability of Serlopitant for Pruritus Itch After Burn Injury
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None